“From 2019 to 2024, the percentage of adult patients with a diagnosis of overweight or obesity increased 50.7 percent, and ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

Weight-loss drugs like Mounjaro and Ozempic work wonders on your waistline but can cause chaos with your scalp. Here’s what ...

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...

Semaglutide and similar peptide drugs bind the G-protein coupled GLP-1 receptor to transfer chemical signals from outside the ...

These new supplemental products are offering similar benefits to drugs like Ozempic — but experts say it may be a placebo effect.

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

Some restaurants are offering smaller menu items to GLP-1 drug users, who eat less when dining out, per The New York Times.